Katz D H, Bargatze R F, Bogowitz C A, Katz L R
J Immunol. 1979 Jun;122(6):2184-90.
Two biologically active serum molecules manifesting precisely opposite biologic effects, both of which are selective for IgE antibody synthesis, can be detected in the serum and ascites fluids of CFA-immune mice. One activity, described previously, is suppressive and hence termed suppressive factor of allergy (SFA); the other, reported for the first time herein, is enhancing and has been termed enhancing factor of allergy (EFA). The ability to detect one vs the other activity requires certain special manipulations such as different doses of low dose x-irradiation. Conclusive evidence for the existence of two distinct factors mediating these two opposing biologic effects was obtained in studies demonstrating that affinity chromatography on concanavalin A-Sepharose segregated the two molecular entities. Thus, SFA binds poorly or not at all to Con A-Sepharose, whereas EFA binds to Con A and can be recovered in the eluate eluted with the competitive sugar alpha-methyl-D-glucopyranoside.
在佐剂性关节炎免疫小鼠的血清和腹水中可检测到两种具有生物活性的血清分子,它们表现出完全相反的生物学效应,且二者均对IgE抗体合成具有选择性。一种活性,先前已有描述,具有抑制作用,因此被称为过敏抑制因子(SFA);另一种,本文首次报道,具有增强作用,被称为过敏增强因子(EFA)。检测一种活性与另一种活性的能力需要某些特殊操作,如不同剂量的低剂量x射线照射。在研究中获得了确凿证据,证明存在两种不同的因子介导这两种相反的生物学效应,这些研究表明,伴刀豆球蛋白A - 琼脂糖亲和层析分离出了这两种分子实体。因此,SFA与伴刀豆球蛋白A - 琼脂糖结合不佳或根本不结合,而EFA与伴刀豆球蛋白A结合,并可在用竞争性糖α - 甲基 - D - 吡喃葡萄糖苷洗脱的洗脱液中回收。